Haleon reports half-year results and declares interim dividend

HLN

Haleon Plc (LON:HLN) has announced its half-year results statement for the year ending 31 December 2026

The half year results statement will also be available on the Haleon website www.haleon.com/investors, and the results have been submitted in full unedited text to the Financial Conduct Authority’s National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Dividend

Subject to market conditions and Board approval, Haleon expects to grow its ordinary dividend at least in line with adjusted earnings.

Presentation for analysts and shareholders

A recorded results presentation by Brian McNamara, Chief Executive Officer, and Dawn Allen, Chief Financial Officer, will be available shortly after 7:00am BST (8:00 am CEST) on 30 July 2026 and can be accessed at www.haleon.com/investors. This will be followed by a Q&A session at 9:00am BST (10:00am CEST).

For analysts and shareholders wishing to ask questions, please use the dial-in details below which will have a Q&A facility:

UK:+44 (0) 808 189 0158
US:+1 855 979 6654
All other:+44 (0) 203 936 2999
Passcode:081063

An archived webcast of the Q&A call will be available later on the day of the results and can be accessed at www.haleon.com/investors.

Share on:

Latest Company News

Haleon reports half-year results and declares interim dividend

Haleon has announced its half-year results, declared a 2.4 pence interim dividend and provided details of its investor presentation.

Haleon reports 2025 results with 3% organic growth and margin expansion

Haleon delivered 3% organic revenue growth in 2025, supported by strong performance in Oral Health and emerging markets. Adjusted operating profit rose 10.5% organically, with margin expansion driven by productivity gains and disciplined investment.

Haleon appoints Vindi Banga as new Chair as Sir Dave Lewis steps down

Haleon has confirmed that Sir Dave Lewis will step down as Chair at the end of December 2025, with Vindi Banga appointed to take over from January 2026.

Haleon delivers 3.4% organic revenue growth in Q3 2025 driven by oral health and VMS

Haleon reported Q3 2025 revenue of £2.8 billion, reflecting 3.4% organic growth, led by strong performances in Oral Health and Vitamins, Minerals and Supplements.

Haleon Plc Q1 2025: £2.85bn revenue, 3.5% organic growth

Haleon plc has released its Q1 trading statement for 2025, with a presentation and Q&A session led by CFO Dawn Allen scheduled for April 30.

Haleon Plc publishes 2024 Annual Report

Haleon plc has released its Annual Report for 2024, detailing vital financial information and upcoming AGM plans. Discover key insights for investors now.

    Search